Llwytho...
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
Hospitalization for acute heart failure (HF) is associated with a substantial morbidity burden and with associated healthcare costs and an increased mortality risk. However, few if any major medical innovations have been witnessed in this area in recent times. Levosimendan is a first‐in‐class calciu...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | ESC Heart Fail |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6351894/ https://ncbi.nlm.nih.gov/pubmed/30378288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12366 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|